Publications

Publications pour l'équipe Oncostat

Titre Publication Type Publication year Auteur
Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial journalArticle 2015 Borget, I.; Bonastre, J.; Catargi, B.; Déandréis, D.; Zerdoud, S.; Rusu, D.; Bardet, S.; Leenhardt, L.; Bastie, D.; Schvartz, C.; Vera, P.; Morel, O.; Benisvy, D.; Bournaud, C.; Bonichon, F.; Kelly, A.; Toubert, M. E.; Leboulleux, S.; Journeau, F.; Benhamou, E.; Schlumberger, M.
Bayesian survival analysis in clinical trials: What methods are used in practice? journalArticle 2017 Brard, C.; Le Teuff, G.; Le Deley, M. C.; Hampson, L. V.
Impact of time to local recurrence on the occurrence of metastasis in breast cancer patients treated with neoadjuvant chemotherapy: A random forest survival approach journalArticle 2019 Laas, E.; Hamy, A. S.; Michel, A. S.; Panchbhaya, N.; Faron, M.; Lam, T.; Carrez, S.; Pierga, J. Y.; Rouzier, R.; Lerebours, F.; Feron, J. G.; Reyal, F.
Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial journalArticle 2016 Jovelet, C.; Ileana, E.; Le Deley, M. C.; Motte, N.; Rosellini, S.; Romero, A.; Lefebvre, C.; Pedrero, M.; Pata-Merci, N.; Droin, N.; Deloger, M.; Massard, C.; Hollebecque, A.; Ferte, C.; Boichard, A.; Postel-Vinay, S.; Ngo-Camus, M.; De Baere, T.; Vielh, P.; Scoazec, J. Y.; Vassal, G.; Eggermont, A.; Andre, F.; Soria, J. C.; Lacroix, L.
Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial journalArticle 2018 Pannier, D.; Adenis, A.; Bogart, E.; Dansin, E.; Clisant-Delaine, S.; Decoupigny, E.; Lesoin, A.; Amela, E.; Ducornet, S.; Meurant, J. P.; Le Deley, M. C.; Penel, N.
Value of a short-term imaging follow-up after a benign result in a one-stop breast unit: Is it still useful? journalArticle 2017 Daroles, J.; Borget, I.; Suciu, V.; Mazouni, C.; Delaloge, S.; Balleyguier, C.
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma journalArticle 2015 Hadoux, J.; Malka, D.; Planchard, D.; Scoazec, J. Y.; Caramella, C.; Guigay, J.; Boige, V.; Leboulleux, S.; Burtin, P.; Berdelou, A.; Loriot, Y.; Duvillard, P.; Chougnet, C. N.; Déandréis, D.; Schlumberger, M.; Borget, I.; Ducreux, M.; Baudin, E.
Phase I trial of bortezomib daily dose: safety, pharmacokinetic profile, biological effects and early clinical evaluation in patients with advanced solid tumors journalArticle 2018 Bahleda, R.; Le Deley, M. C.; Bernard, A.; Chaturvedi, S.; Hanley, M.; Poterie, A.; Gazzah, A.; Varga, A.; Touat, M.; Deutsch, E.; Massard, C.; Van De Velde, H.; Hollebecque, A.; Sallansonnet-Froment, M.; Ricard, D.; Taillia, H.; Angevin, E.; Ribrag, V.; Soria, J. C.
[Individualization of dose and fractionation of radiotherapy for head and neck cancers] journalArticle 2019 Blanchard, P.; Biau, J.; Castelli, J.; Tao, Y.; Graff, P.; Nguyen, F.
Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells journalArticle 2016 Mittal, D.; Caramia, F.; Michiels, S.; Joensuu, H.; Kellokumpu-Lehtinen, P. L.; Sotiriou, C.; Loi, S.; Smyth, M. J.
Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review journalArticle 2015 Mamelle, E.; Borget, I.; Leboulleux, S.; Mirghani, H.; Suárez, C.; Pellitteri, P. K.; Shaha, A. R.; Hamoir, M.; Robbins, K. T.; Khafif, A.; Rodrigo, J. P.; Silver, C. E.; Rinaldo, A.; Ferlito, A.; Hartl, D. M.
Evaluation of Treatment Effect with Paired Failure Times in a Single-Arm Phase II Trial in Oncology journalArticle 2018 Texier, M.; Rotolo, F.; Ducreux, M.; Bouché, O.; Pignon, J. P.; Michiels, S.
Mineralogy and uranium leaching of ores from Triassic Peribaltic sandstones journalArticle 2015 Gajda, D.; Kiegiel, K.; Zakrzewska-Koltuniewicz, G.; Chajduk, E.; Bartosiewicz, I.; Wolkowicz, S.
Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies journalArticle 2016 Postel-Vinay, S.; Aspeslagh, S.; Lanoy, E.; Robert, C.; Soria, J. C.; Marabelle, A.
Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial journalArticle 2016 Blanchard, P.; Faivre, L.; Lesaunier, F.; Salem, N.; Mesgouez-Nebout, N.; Deniau-Alexandre, E.; Rolland, F.; Ferrero, J. M.; Houede, N.; Mourey, L.; Theodore, C.; Krakowski, I.; Berdah, J. F.; Baciuchka, M.; Laguerre, B.; Davin, J. L.; Habibian, M.; Culine, S.; Laplanche, A.; Fizazi, K.
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) journalArticle 2015 Gourgou-Bourgade, S.; Cameron, D.; Poortmans, P.; Asselain, B.; Azria, D.; Cardoso, F.; A'Hern, R.; Bliss, J.; Bogaerts, J.; Bonnefoi, H.; Brain, E.; Cardoso, M. J.; Chibaudel, B.; Coleman, R.; Cufer, T.; Dal Lago, L.; Dalenc, F.; De Azambuja, E.; Debled, M.; Delaloge, S.; Filleron, T.; Gligorov, J.; Gutowski, M.; Jacot, W.; Kirkove, C.; MacGrogan, G.; Michiels, S.; Negreiros, I.; Offersen, B. V.; Penault Llorca, F.; Pruneri, G.; Roche, H.; Russell, N. S.; Schmitt, F.; Servent, V.; Thürlimann, B.; Untch, M.; van der Hage, J. A.; van Tienhoven, G.; Wildiers, H.; Yarnold, J.; Bonnetain, F.; Mathoulin-Pélissier, S.; Bellera, C.; Dabakuyo-Yonli, T. S.
Optimizing Local Control in High-Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal Treatment journalArticle 2017 Annede, P.; Gouy, S.; Mazeron, R.; Bentivegna, E.; Maroun, P.; Petit, C.; Dumas, I.; Leary, A.; Genestie, C.; Lhomme, C.; Deutsch, E.; Morice, P.; Pautier, P.; Haie-Meder, C.; Chargari, C.
Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients journalArticle 2016 Deutsch, E.; Haie-Meder, C.; Bayar, M. A.; Mondini, M.; Laporte, M.; Mazeron, R.; Adam, J.; Varga, A.; Vassal, G.; Magne, N.; Chargari, C.; Lanoy, E.; Pautier, P.; Levy, A.; Soria, J. C.
Proton versus photon radiation-induced cell death in head and neck cancer cells journalArticle 2019 Wang, L.; Han, S.; Zhu, J.; Wang, X.; Li, Y.; Wang, Z.; Lin, E.; Wang, X.; Molkentine, D. P.; Blanchard, P.; Yang, Y.; Zhang, R.; Sahoo, N.; Gillin, M.; Zhu, X. R.; Zhang, X.; Myers, J. N.; Frank, S. J.
Prevalence of burnout, depression and job satisfaction among French senior and resident radiation oncologists journalArticle 2018 Lazarescu, I.; Dubray, B.; Joulakian, M. B.; Blanchard, P.; Chauvet, B.; Mahe, M. A.; Mornex, F.; Rocher, F.; Thureau, S.
A Dual Model for Prioritizing Cancer Mutations in the Non-coding Genome Based on Germline and Somatic Events journalArticle 2015 Li, J.; Poursat, M. A.; Drubay, D.; Motz, A.; Saci, Z.; Morillon, A.; Michiels, S.; Gautheret, D.
In the immuno-oncology era, is anti-PD-1 or anti-PD-L1 immunotherapy modifying the sensitivity to conventional cancer therapies? journalArticle 2017 Aspeslagh, S.; Matias, M.; Palomar, V.; Dercle, L.; Lanoy, E.; Soria, J. C.; Postel-Vinay, S.
Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients journalArticle 2016 Deutsch, E.; Haie-Meder, C.; Bayar, M. A.; Mondini, M.; Laporte, M.; Mazeron, R.; Adam, J.; Varga, A.; Vassal, G.; Magne, N.; Chargari, C.; Lanoy, E.; Pautier, P.; Levy, A.; Soria, J. C.
Choline Positron Emission Tomography/Computed Tomography for Selection of Patients for Salvage Strategies After Primary Local Treatment of Prostate Cancer and Rising Prostate-specific Antigen: Ready for Prime Time? journalArticle 2017 Bossi, A.; Mottet, N.; Blanchard, P.
The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence journalArticle 2016 Ignatiadis, M.; Azim, H. A.; Desmedt, C.; Veys, I.; Larsimont, D.; Salgado, R.; Lyng, M. B.; Viale, G.; Leyland-Jones, B.; Giobbie-Hurder, A.; Kammler, R.; Dell'Orto, P.; Rothe, F.; Laios, I.; Ditzel, H. J.; Regan, M. M.; Piccart, M.; Michiels, S.; Sotiriou, C.
Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy journalArticle 2018 Ou, D.; Garberis, I.; Adam, J.; Blanchard, P.; Nguyen, F.; Levy, A.; Casiraghi, O.; Gorphe, P.; Breuskin, I.; Janot, F.; Temam, S.; Scoazec, J. Y.; Deutsch, E.; Tao, Y.
A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies journalArticle 2015 Rini, B.; Goddard, A.; Knezevic, D.; Maddala, T.; Zhou, M.; Aydin, H.; Campbell, S.; Elson, P.; Koscielny, S.; Lopatin, M.; Svedman, C.; Martini, J. F.; Williams, J. A.; Verkarre, V.; Radulescu, C.; Neuzillet, Y.; Hemmerle, I.; Timsit, M. O.; Tsiatis, A. C.; Bonham, M.; Lebret, T.; Mejean, A.; Escudier, B.
Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study journalArticle 2017 Colomba, E.; Le Teuff, G.; Eisen, T.; Stewart, G. D.; Fife, K.; Larkin, J.; Biondo, A.; Pickering, L.; Srinivasan, A.; Boyle, H.; Derosa, L.; Sternberg, C. N.; Recine, F.; Ralph, C.; Saldana, C.; Barthélémy, P.; Bernhard, J. C.; Gurney, H.; Verhoest, G.; Vauleon, E.; Bigot, P.; Berger, J.; Pfister, C.; Gravis, G.; Rodier, J. M.; Culine, S.; Caty, A.; Rolland, F.; Priou, F.; Escudier, B.; Albiges, L.
Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials journalArticle 2016 Le Tourneau, C.; Kamal, M.; Tsimberidou, A. M.; Bedard, P.; Pierron, G.; Callens, C.; Rouleau, E.; Vincent-Salomon, A.; Servant, N.; Alt, M.; Rouzier, R.; Paoletti, X.; Delattre, O.; Bieche, I.
The Use of Indirect Comparisons in Medicines Evaluation for their Access To Reimbursement by the Has journalArticle 2015 Guichard, M.; D'Andon, A.; Rumeau Pichon, C.; Borget, I.
Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial journalArticle 2018 Bahig, H.; Yuan, Y.; Mohamed, A. S. R.; Brock, K. K.; Ng, S. P.; Wang, J.; Ding, Y.; Hutcheson, K.; McCulloch, M.; Balter, P. A.; Lai, S. Y.; Al-Mamgani, A.; Sonke, J. J.; van der Heide, U. A.; Nutting, C.; Li, X. A.; Robbins, J.; Awan, M.; Karam, I.; Newbold, K.; Harrington, K.; Oelfke, U.; Bhide, S.; Philippens, M. E. P.; Terhaard, C. H. J.; McPartlin, A. J.; Blanchard, P.; Garden, A. S.; Rosenthal, D. I.; Gunn, G. B.; Phan, J.; Cazoulat, G.; Aristophanous, M.; McSpadden, K. K.; Garcia, J. A.; van den Berg, C. A. T.; Raaijmakers, C. P. J.; Kerkmeijer, L.; Doornaert, P.; Blinde, S.; Frank, S. J.; Fuller, C. D.
The association between coffee consumption and bladder cancer in the bladder cancer epidemiology and nutritional determinants (BLEND) international pooled study journalArticle 2019 Yu, E. Y.; Wesselius, A.; van Osch, F.; Stern, M. C.; Jiang, X.; Kellen, E.; Lu, C. M.; Pohlabeln, H.; Steineck, G.; Marshall, J.; Allam, M. F.; La Vecchia, C.; Johnson, K. C.; Benhamou, S.; Zhang, Z. F.; Bosetti, C.; Taylor, J. A.; Zeegers, M. P.
Statistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practice journalArticle 2016 Michiels, S.; Ternes, N.; Rotolo, F.
Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial journalArticle 2018 Tao, Y.; Auperin, A.; Sire, C.; Martin, L.; Khoury, C.; Maingon, P.; Bardet, E.; Kaminsky, M. C.; Lapeyre, M.; Chatellier, T.; Alfonsi, M.; Pointreau, Y.; Jadaud, E.; Géry, B.; Zawadi, A.; Tourani, J. M.; Laguerre, B.; Coutte, A.; Racadot, S.; Hasbini, A.; Malaurie, E.; Borel, C.; Meert, N.; Cornely, A.; Ollivier, N.; Casiraghi, O.; Sun, X. S.; Bourhis, J.
Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study journalArticle 2018 Gaspar, N.; Occean, B. V.; Pacquement, H.; Bompas, E.; Bouvier, C.; Brisse, H. J.; Castex, M. P.; Cheurfa, N.; Corradini, N.; Delaye, J.; Entz-Werle, N.; Gentet, J. C.; Italiano, A.; Lervat, C.; Marec-Berard, P.; Mascard, E.; Redini, F.; Saumet, L.; Schmitt, C.; Tabone, M. D.; Verite-Goulard, C.; Le Deley, M. C.; Piperno-Neumann, S.; Brugieres, L.; Sfce; Gsf, Geto; group, Unicancer sarcoma
Designs of preoperative biomarkers trials in oncology: a systematic review of the literature journalArticle 2015 Marous, M.; Bieche, I.; Paoletti, X.; Alt, M.; Razak, A. R.; Stathis, A.; Kamal, M.; Le Tourneau, C.
A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer journalArticle 2018 Criscitiello, C.; Bayar, M. A.; Curigliano, G.; Symmans, F. W.; Desmedt, C.; Bonnefoi, H.; Sinn, B.; Pruneri, G.; Vicier, C.; Pierga, J. Y.; Denkert, C.; Loibl, S.; Sotiriou, C.; Michiels, S.; André, F.
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis journalArticle 2015 Blanchard, P.; Lee, A.; Marguet, S.; Leclercq, J.; Ng, W. T.; Ma, J.; Chan, A. T.; Huang, P. Y.; Benhamou, E.; Zhu, G.; Chua, D. T.; Chen, Y.; Mai, H. Q.; Kwong, D. L.; Cheah, S. L.; Moon, J.; Tung, Y.; Chi, K. H.; Fountzilas, G.; Zhang, L.; Hui, E. P.; Lu, T. X.; Bourhis, J.; Pignon, J. P.; Group, Mac-Npc Collaborative
Safety, tolerability and antitumour activity of LY2780301 (p70S6K/AKT inhibitor) in combination with gemcitabine in molecularly selected patients with advanced or metastatic cancer: a phase IB dose escalation study journalArticle 2017 Angevin, E.; Cassier, P. A.; Italiano, A.; Goncalves, A.; Gazzah, A.; Terret, C.; Toulmonde, M.; Gravis, G.; Varga, A.; Parlavecchio, C.; Paci, A.; Poinsignon, V.; Soria, J. C.; Drubay, D.; Hollebecque, A.
Nail toxicities induced by systemic anticancer treatments journalArticle 2015 Robert, C.; Sibaud, V.; Mateus, C.; Verschoore, M.; Charles, C.; Lanoy, E.; Baran, R.